news research: critical evaluation of pharmaceutical/health industry resources paul brock knowledge...

13
News Research: Critical Evaluation of Pharmaceutical/Health Industry Resources Paul Brock Knowledge Integration Leader, Therapeutic Areas Gerri Klumpp Senior Knowledge Integrator, Drug Development Knowledge Management AstraZeneca Pharmaceuticals LP

Upload: julian-ramsey

Post on 26-Dec-2015

215 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: News Research: Critical Evaluation of Pharmaceutical/Health Industry Resources Paul Brock Knowledge Integration Leader, Therapeutic Areas Gerri Klumpp

News Research: Critical Evaluation of Pharmaceutical/Health Industry

Resources

Paul Brock

Knowledge Integration Leader, Therapeutic Areas

Gerri Klumpp

Senior Knowledge Integrator, Drug Development

Knowledge Management

AstraZeneca Pharmaceuticals LP

Page 2: News Research: Critical Evaluation of Pharmaceutical/Health Industry Resources Paul Brock Knowledge Integration Leader, Therapeutic Areas Gerri Klumpp

Additional AstraZeneca Experts

• Linda Gabriel: Knowledge Integrator, Drug Development• Judy Bush: Knowledge Integrator, GI Therapeutic Area• Ann Fieles: Knowledge Integrator, Oncology Therapeutic Area• Cathy Wagner: Knowledge Integrator, CNS Therapeutic Area• Susan Zalenski: Knowledge Integrator, CV Therapeutic Area• Lillian Torres: Knowledge Integrator, Licensing

Page 3: News Research: Critical Evaluation of Pharmaceutical/Health Industry Resources Paul Brock Knowledge Integration Leader, Therapeutic Areas Gerri Klumpp

Assumptions AboutResource Accessibility

• Pharmaceutical-specific resources are subscribed to, whether in electronic or printed form (e.g., The Pink Sheet, market research reports [such as Decision Resources])

• Lexis-Nexis• Dialog• Other major news &

newswire services (e.g., Dow Jones Interactive)

• Internet• A library• A phone

No… Yes…

Page 4: News Research: Critical Evaluation of Pharmaceutical/Health Industry Resources Paul Brock Knowledge Integration Leader, Therapeutic Areas Gerri Klumpp

Resource Scope

• “Journalist-friendly” resources• Technical knowledge not required

• “Key” resources• By no means a comprehensive list

• Web-based resources• Most effort place here because everyone should have

access• Non-fee-based (in most cases)

• Dialog, but with valiant attempt at Lexis-Nexis• Reputable resources

Focus on…

Page 5: News Research: Critical Evaluation of Pharmaceutical/Health Industry Resources Paul Brock Knowledge Integration Leader, Therapeutic Areas Gerri Klumpp

Examples of Research Requests

• Mad Cow Disease• Locating and contacting U.S. authorities and experts• How to best track the impact of Mad Cow disease on the U.S.

beef industry and the entire U.S. food distribution network• How to identify and track regulatory responsibilities for the

disease at both the Federal and state level • Investigative resources for tracking the path of the disease into

the U.S. and who might be responsible• Emerging Prescription Drugs

• Identify important emerging drugs• Ways to follow pharmaceutically, legally and politically

the path of drugs through the FDA approval process

Page 6: News Research: Critical Evaluation of Pharmaceutical/Health Industry Resources Paul Brock Knowledge Integration Leader, Therapeutic Areas Gerri Klumpp

More Research Requests

• Phthalates, a chemical in vinyl that is harmful to children• Permanent cosmetics• Internet pharmacies• Alcoholism as a disease• Secretary Donna Shalala and her advisory group on genetic testing• Effects of electromagnetic fields on human health, particularly with

cell phones• Limb reattachment surgery• How pharmaceutical industry influences doctors & HMOs to

“push” specific drugs, including statistics on pharmaceutical industry, drug costs, pharmaceutical lobbying, etc.

Information on…

Page 7: News Research: Critical Evaluation of Pharmaceutical/Health Industry Resources Paul Brock Knowledge Integration Leader, Therapeutic Areas Gerri Klumpp

Approach for This Session

• Resources for broad list of categories & sub-categories• Web-based• Commercial database service-based• Print-based• Other

• Resources & approaches for specific research scenarios

• Recommended Knowledge Management approaches

Page 8: News Research: Critical Evaluation of Pharmaceutical/Health Industry Resources Paul Brock Knowledge Integration Leader, Therapeutic Areas Gerri Klumpp

Pharmaceuticals

Health & Medicine

Health Care Industry

•Emerging Products•Drug Costs•Government & Regulatory•Industry & Lobby Groups•Experts

•Consumer•Environment•Nutrition•Disease States •Government & Regulatory•Experts

•Management•Costs•Policy•Experts

Categories Sub-categories Resources

•Web•Commercial Online Services•Print

Page 9: News Research: Critical Evaluation of Pharmaceutical/Health Industry Resources Paul Brock Knowledge Integration Leader, Therapeutic Areas Gerri Klumpp

Let’s go to the Handout!

Microsoft Word Document

Page 10: News Research: Critical Evaluation of Pharmaceutical/Health Industry Resources Paul Brock Knowledge Integration Leader, Therapeutic Areas Gerri Klumpp

Other Resources

• Search Engines & Portals• E.g., Yahoo, Google

• Snow B. Drug Information: A Guide to Current Resources. 2nd ed. Lanham, MD: The Scarecrow Press, 1999.

• Knowledge Sharing• “Communities of Practice”

– In-house– Listservs, including SLA

– Pharm Division: Membership to the Pharm Division is required to subscribe, but may be worth it

• Processes– Develop processes for improving information flow

• Tools– Databases for capturing searches, contacts, experts

Page 11: News Research: Critical Evaluation of Pharmaceutical/Health Industry Resources Paul Brock Knowledge Integration Leader, Therapeutic Areas Gerri Klumpp

Examples of Research Requests

• Mad Cow Disease1. Locating and contacting U.S. authorities

and experts2. How to best track the impact of Mad Cow

disease on the U.S. beef industry and the entire U.S. food distribution network

3. How to identify and track regulatory responsibilities for the disease at both the Federal and state level

4. Investigative resources for tracking the path of the disease into the U.S. and who might be responsible

• Emerging Prescription Drugs1. Identify important emerging drugs2. Ways to follow pharmaceutically,

legally and politically the path of drugs through the FDA approval process

1. Health & Medicine/Experts

2. Health & Medicine/Food & Nutrition

3. Health & Medicine/Government & Regulatory

4. Health & Medicine/Food & Nutrition or Health & Medicine/Environment

5. Pharmaceutical/Emerging Products

6. Pharmaceutical/Emerging Products or Pharmaceutical/Government & Regulatory

Category/SubcategoryResearch Request

Page 12: News Research: Critical Evaluation of Pharmaceutical/Health Industry Resources Paul Brock Knowledge Integration Leader, Therapeutic Areas Gerri Klumpp

More Research Requests

1. Phthalates, a chemical in vinyl that is harmful to children

2. Permanent cosmetics

3. Internet pharmacies

4. Alcoholism as a disease5. Secretary Donna Shalala and her

advisory group on genetic testing6. Effects of electromagnetic fields on

human health, particularly with cell phones

7. Limb reattachment surgery8. Statistics on pharmaceutical industry

statistics, drug costs, pharmaceutical lobbying, etc.

1. Health & Medicine/Environment

2. Health & Medicine/Consumer Health or Health & Medicine/Government & Regulatory

3. Health & Medicine/Consumer Health or Health & Medicine/Government & Regulatory or Pharmaceutical/Pharmaceutical Industry

4. Health & Medicine/Disease States5. Health & Medicine/Government & Regulatory

6. Health & Medicine/Consumer Health or Health & Medicine/Disease States or Health & Medicine/Environment

7. Health & Medicine/Disease States8. Pharmaceutical/Pharmaceutical Industry or

Pharmaceutical/Costs, Sales, Pricing or Pharmaceutical/Government & Regulatory or Health Care Industry/Policy

Research Request Category/Subcategory

Page 13: News Research: Critical Evaluation of Pharmaceutical/Health Industry Resources Paul Brock Knowledge Integration Leader, Therapeutic Areas Gerri Klumpp

Any more questions?